Related references
Note: Only part of the references are listed.Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis-Should MMF Be Considered the Drug of Choice?
Brad H. Rovin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome
Desmond Y. H. Yap et al.
NEPHROLOGY (2012)
Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis
Xiao Li et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Understanding lupus nephritis: diagnosis, management, and treatment options
Chi Chiu Mok
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2012)
Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial
Wei Chen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Randomized Trial of Immunosuppressive Regimens in Renal Transplantation
Giselle Guerra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Present and Future of Immunosuppressive Therapy in Kidney Transplantation
C. Ponticelli
TRANSPLANTATION PROCEEDINGS (2011)
Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis
C. M. Lanata et al.
LUPUS (2010)
Predictors of Relapse and End Stage Kidney Disease in Proliferative Lupus Nephritis: Focus on Children, Adolescents, and Young Adults
Keisha L. Gibson et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The role of tacrolimus in renal transplantation
Lyndsey J. Bowman et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Successful treatment of class V+IV lupus nephritis with multitarget therapy
Hao Bao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis
C. -C. Szeto et al.
RHEUMATOLOGY (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide
CC Mok et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study
CC Mok et al.
KIDNEY INTERNATIONAL (2005)
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial
JP Buyon et al.
ANNALS OF INTERNAL MEDICINE (2005)
Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation:: 2 year follow-up results
BK Krämer et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis
CC Mok et al.
ARTHRITIS AND RHEUMATISM (2004)
Mycophenolic acid inhibits inosine 5 '-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells
CA Jonsson et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Tacrolimus - A further update of its use in the management of organ transplantation
LJ Scott et al.
DRUGS (2003)
Mycophenolate mofetil in lupus glomerulonephritis
CC Mok et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production
HS Jiang et al.
TRANSPLANTATION (2002)